219 filings
Page 6 of 11
6-K
e0d1j7mc wbysi15k2
14 Jan 21
Current report (foreign)
7:06am
6-K
cumlrax7figq
17 Dec 20
Mereo BioPharma and Ultragenyx Announce Collaboration and License
5:16pm
6-K
q9j0d
15 Dec 20
Current report (foreign)
2:22pm
6-K
91gtwb4hx 3rqm
16 Nov 20
Current report (foreign)
7:27am
6-K
pvgnqf2dznbir
12 Nov 20
Current report (foreign)
6:15am
424B5
hsjy3motxu59lt
23 Oct 20
Prospectus supplement for primary offering
4:40pm
EFFECT
r5077z
22 Oct 20
Notice of effectiveness
12:15am
6-K
8gqouosy26j
20 Oct 20
Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs
7:12am
CORRESP
e7b772pbpdw
20 Oct 20
Correspondence with SEC
12:00am
6-K
drk suqnmnvo0yb
19 Oct 20
Current report (foreign)
8:10am
6-K
ayc65y
13 Oct 20
Current report (foreign)
8:00am
6-K
xeb7n5s4t2q
9 Oct 20
Current report (foreign)
4:05pm
UPLOAD
8w8ff
9 Oct 20
Letter from SEC
12:00am
6-K
3wcejv7 ix1lg9
7 Oct 20
Mereo BioPharma Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission
9:53am
F-3
rrdkzrs
6 Oct 20
Shelf registration (foreign)
4:25pm
F-6EF
r5l28tkv 4qv
6 Oct 20
Automatic registration for ADRs (foreign)
4:10pm
6-K
hgqc p5zen
1 Oct 20
Current report (foreign)
4:30pm
6-K
5vomsxc
29 Sep 20
Current report (foreign)
7:08am
6-K
xs29jswn887von4mx
28 Sep 20
Result of General Meeting
4:43pm
6-K
txgd0bp d25oh
28 Sep 20
Mereo BioPharma Announces Changes to Board of Directors
8:08am